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Aims: Chronic cocaine users display impaired social cognitive abilities, reduced prosocial 
behavior, and pronounced cluster B personality disorder (PD) symptoms all contributing 
to their social dysfunctions in daily life. These social dysfunctions have been proposed 
as a major factor for maintenance and relapse of stimulant use disorders in general. 
However, little is known about the reversibility of social cognitive deficits and socially 
problematic personality facets when stimulant use is reduced or ceased. Therefore, we 
examined the relation between changing intensity of cocaine use and the development of 
sociocognitive functioning and cluster B PD symptomatology over the course of 1 year.
Methods: Social cognition, social decision-making, and cluster B PD symptoms were 
assessed in 38 cocaine users (19 with increased and 19 with decreased use) and 48 
stimulant-naive healthy controls at baseline and at 1-year follow-up. Cocaine use severity 
was objectively determined by quantitative 6-month hair analyses. The categorization 
of the two cocaine user groups was based on a combination of absolute (± 0.5 ng/
mg) and relative (± 10%) changes in the cocaine hair concentration between baseline 
and the 1-year follow-up. Social cognition was assessed using the Multifaceted Empathy 
Test (MET) and the Movie for the Assessment of Social Cognition (MASC). A combined 
Distribution/Dictator Game was applied for assessing social decision-making. Cluster 
B PD symptoms were measured by a Structured Clinical Interview for DSM-IV Axis II 
Disorders (SCID-II) PD questionnaire according to Diagnostic and Statistical Manual of 
Mental Disorders, 4th edition (DSM-IV).
Results: Increased cocaine use was linked to worsened empathy, while decreased cocaine 
use went along with improved emotional empathy. Moreover, whereas decreased cocaine 
use was associated with reduced severity of self-reported cluster B PD symptoms, these 
symptoms remained largely stable in increasers. In contrast to a significant reduction of 
prosocial behavior at baseline in the combined cocaine user group, specifically decreasers 
were not statistically distinguishable from controls at the follow-up.
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Conclusions: Sociocognitive deficits and cluster B PD symptoms of chronic cocaine 
users are adaptable over time as they covary with the increase or decrease in cocaine 
use. Hence, abstinence orientation and training of social cognition and interaction might 
improve social functioning, and should therefore be important therapeutic elements in 
cocaine addiction treatment.
Keywords: cocaine, stimulants, social cognition, empathy, Theory-of-Mind, social decision-making, cognition, 
personality disorder
INTRODUCTION
Neurocognitive deficits such as impaired attention, memory, 
and executive functions related to chronic cocaine use are 
well documented (1–3) and a risk factor for poor treatment 
outcomes (4, 5). While some studies investigated the linkage 
between these neurocognitive deficits and cocaine abstinence 
(6), only one study yet investigated the longitudinal relationship 
between cognitive impairments and changing cocaine use (7). 
In sum, these studies indicate that basal cognitive deficits in 
cocaine users seem to be largely drug-induced, remain stable 
during the first weeks of abstinence but likely improve after 
some months (8).
While nonsocial cognitive functions have been studied 
well during the last two decades, the systematic assessment of 
sociocognitive functioning in cocaine users has only recently 
emerged. Per definition, the concept of social cognition 
comprises not only abilities enabling the dynamic interaction 
with our social environments and include emotional and 
mental perspective-taking functions such as emotion 
recognition, emotional empathy (EE), and Theory-of-Mind, 
but also interactive abilities such as social decision-making 
(SDM), moral behavior, and social network behavior (9, 10). As 
daily-life social functioning strongly depends on intact social 
cognition and as the deteriorative impact of sociocognitive 
impairments on development, progress, and prognosis on 
other psychiatric disorders such as schizophrenia is well known 
(11), a close relationship between sociocognitive functioning 
and the origin and course of stimulant use disorders has been 
proposed (12–15). Accordingly, we previously demonstrated 
smaller social networks (16), reduced EE (16), altered SDM 
(17), stronger detachment from social norms (14), and 
impaired emotion recognition from voices (18) in recreational 
and dependent cocaine user groups. Moreover, dependent 
cocaine users made more errors than controls in a video-
based Theory-of-Mind task, with recreational cocaine users 
performing intermediate between the two groups (16). Finally, 
cocaine users show also blunted neuronal responses to implicit 
and explicit forms of social reward (19, 20). Notably, all these 
studies were implemented with a cross-sectional design, 
but no study has investigated the longitudinal development 
of sociocognitive functioning so far. Thus, it is unclear if 
sociocognitive impairments are predisposed or drug-induced 
and if they are reversible upon prolonged abstinence or 
reduction of drug use.
As social cognition is the sum of those processes that allow 
individuals to interact in interpersonal contexts (21), disturbed 
sociocognitive functioning leads to aberrant social behavior 
and, in excessive forms, to deviant personality characteristics 
and impaired interpersonal functioning (22, 23). Notably, 
cocaine-addicted individuals show an increased risk for 
concurrent cluster B personality disorders (PDs), mainly of 
the antisocial and borderline types (24, 25). A cluster B PD 
comorbidity is largely influential for cocaine addiction severity 
and treatment outcomes including pronounced executive 
function deficits (26), more intense cocaine intake, lower rates 
of treatment applications, and decreased probability of cocaine 
addiction remission (27, 28). Additionally, it was demonstrated 
that impulsivity and gambling decision-making, which are 
both closely related to cluster B PD pathologies (22, 29), covary 
with changes in the intensity of cocaine use over 1 year (30). 
Nonetheless, the longitudinal relation between cocaine use 
intensity and cluster B PD symptomatology has also not been 
investigated to date.
In sum, only little is known about the temporal dynamics 
between cocaine use intensity and sociocognitive functioning. 
Hence, in order to investigate whether the described sociocognitive 
impairments and comorbid cluster B PD symptomatology in 
chronic cocaine users are modulated by the increase or decrease 
in cocaine abuse, we performed a longitudinal study with an 
interval of 1 year. Thereby, we compared 48 psychostimulant-
naive controls with 19 cocaine users with decreased use 
(decreasers) and 19 cocaine users with increased use (increasers) 
after a 1-year interval. To objectively assess the severity and 
change in cocaine use and to control for co-use of other drugs, 
we performed quantitative hair and urine toxicology analyses at 
baseline and follow-up. Considering our previous results from 
the present sample that changes in basal cognitive functions 
and impulsivity clearly covary with cocaine use intensity over 
time (7, 30), we hypothesized that escalating cocaine use is also 
associated with aggravation of sociocognitive impairments and 
more cluster B PD symptoms within 1 year. Vice versa, we also 
expected that reduced cocaine use is linked to a reduction of 
sociocognitive deficits and cluster B PD symptomatology. To test 
these hypotheses, we expect significant time × group interactions 
specifically between decreasers and increasers. Given that at 
baseline cocaine users displayed significant alterations in EE, 
social network size, prosocial behavior in money distribution 
games, Theory-of-Mind, and cluster B PD symptoms (14, 16, 17), 
the longitudinal analysis was focused solely on these parameters.
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METHODS
Participants
From a baseline sample of 234 participants (96 healthy 
stimulant-naive controls, 138 cocaine users) (3, 16, 17), 48 
healthy stimulant-naive controls and 38 chronic cocaine users 
were included in the present longitudinal study. This subsample 
has been published twice previously but with different outcome 
measures (7, 30). From the baseline sample, 102 participants 
could not be measured at the follow-up because of unavailability 
(i.e., not responding to the invitation, loss of interest, lack of time, 
death), 27 participants had to be excluded from the final analyses 
as hair analyses revealed drug use not allowed by our exclusion 
criteria (e.g., polysubstance use, change in drug preferences), and 
19 cocaine users did not meet our cocaine use criteria [see also 
the cocaine user group assignment below; for further recruitment 
and selection details, please see Ref. (7)].
At baseline, general exclusion criteria were clinically significant 
somatic diseases, neurological disorders, head injuries, family 
history of schizophrenia/obsessive-compulsive disorder/bipolar 
disorder, or any medication affecting the central nervous system. 
Additional exclusion criteria for controls were Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV) 
axis I psychiatric disorders (excluding nicotine dependence) 
and regular illegal drug use (>15 lifetime occasions, except for 
recreational cannabis use). Additional exclusion criteria for 
cocaine users were a history of heroin use, polysubstance use, 
or DSM-IV axis I psychiatric disorders (except for cocaine, 
nicotine, cannabis, and alcohol abuse/dependence, attention 
deficit hyperactivity disorder, and a previous episode of an 
affective disorder). At baseline, inclusion criteria for cocaine 
users were cocaine use of >0.5 g per month, cocaine as primary 
drug, and an abstinence duration of <6 months. Participants 
were asked to abstain from illegal substances for at least 72 h 
and from alcohol for 24 h before the test sessions. Compliance 
with these instructions was controlled by urine screenings 
(semiquantitative enzyme multiplied immunoassay method). 
The study was approved by the Cantonal Ethics Committee of 
Zurich. All participants provided written informed-consent 
statements and were compensated for their participation.
Cocaine User Group Assignment
The categorization of the two cocaine user groups was based on 
changes of cocaine concentration in hair samples as determined 
by liquid chromatography–tandem mass spectrometry [for 
technical details, see Ref. (3)]. If possible, 6-cm hair samples were 
drawn covering the previous drug use of approximately 6 months. 
Cocaine users were categorized based on a combination of 
absolute (±0.5 ng/mg) and relative (>10% increase/decrease) 
changes in the hair concentration of cocainetotal between baseline 
and the 1-year follow-up (7, 30, 31). According to these criteria, 
cocaine users were divided into three equally sized groups: 19 
cocaine increasers [mean ± SD: +30.4 ± 61.9 ng/mg (+297%), 
range: +0.5 to +268.5 ng/mg (+20% to +5,374%)], 19 cocaine 
decreasers [−10.6 ± 26.7 ng/mg (−72%), −116.9 to −0.6 ng/mg 
(−100% to −12%)]), and 19 users with a relatively low and stable 
cocaine use pattern who did not meet both criteria [−0.1 ± 
0.5 ng/mg (−2%), −1.9 to +0.5 ng/mg (−100% to +720%)], and, 
thus, were not further analyzed in this study [for further details, 
see Ref. (7)].
Procedure
At baseline, self-reported drug use was assessed with a structured 
and standardized Interview for Psychotropic Drug Consumption 
(32), attention deficit hyperactivity disorder (ADHD) symptoms 
were assessed with the ADHD Self-Rating Scale (ADHD-SR) 
(33), and the Structured Clinical Interview for DSM-IV axis I 
disorders (SCID-I) (34) was carried out by trained psychologists.
The test battery was assessed at baseline and follow-up and 
included the Multifaceted Empathy Test (MET) (35) assessing EE, 
the Movie for the Assessment of Social Cognition (MASC) (36) 
for the measurement of Theory-of-Mind, a Distribution/Dictator 
Game (37, 38) for the determination of prosocial behavior, the 
Social Network Questionnaire (SNQ) (39) measuring the social 
network size, and the SCID-II questionnaire (40) in order to 
ascertain cluster B PD symptoms. More detailed test descriptions 
published already in our previous work (16, 17) are given in 
Methods S1.
Statistical Analysis
Effect sizes and power analyses were calculated with G*Power 3.1 
(41). As our previous analyses showed an effect size of pη2 = 0.12 
(Cohen’s f = 0.37) and a power of 99% for the significant 
interaction in the domain of working memory between decreasers 
and increasers (two groups, p < .05, two measurements) for the 
present sample (7), we assumed a more conservative effect size 
of pη2 = 0.06 (f = 0.25) and calculated a still acceptable power of 
86% for the detection of significant interactions in sociocognitive 
functions in the present sample.
In order to reduce data quantity [see also Ref. (17)], we 
computed an SDM composite score that was derived by averaging 
z-transformed payoffs for the other player in the Distribution and 
Dictator Game (payoffs B) according to the means and standard 
deviations of the control group. Because of a strong correlation 
of the explicit and implicit EE scores from the MET in the total 
sample (r = 0.86, p < .001), we further integrated both parameters 
by adding them up into a single MET EE score. The SCID-II Cluster 
B symptom score was calculated by summing up the dimensional 
values from histrionic, narcissistic, borderline, and antisocial PD.
Group differences in demographic data and drug use patterns 
were analyzed by means of Pearson’s chi-squared tests, analyses 
of variance (ANOVA), or independent Student’s t-tests. For the 
longitudinal analysis and in order to investigate group differences 
over all groups, we performed a multiple linear regression 
(forced entry) with the test score change values (Δ = t2 − t1) as 
dependent variables and four preselected independent variables: 
age, sex, ADHS-SR score, and dummy-coded (zero/one) group 
contrasts. The two demographic variables were included because 
previous findings suggest a linkage between advancing age and 
fairness in stimulant users (17) and due to known gender effects 
in social cognition/functioning (42, 43). Moreover, because 
ADHD has previously been linked to cognitive and sociocognitive 
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performance in cocaine users (3, 16, 44), this variable was further 
included as a predictor into the regression model. To compare the 
groups, cocaine increasers acted as the reference group. To further 
analyze test score changes within the single groups (value t2 vs. 
value t1), we applied dependent Student’s t-tests (tdep). To compare 
the effect of changing cocaine use, we applied independent 
Student’s t-tests (tind) between controls and a combined cocaine 
user sample (CCU = increasers + decreasers) at baseline as well as 
between controls, cocaine increasers, and cocaine decreasers at the 
follow-up. Notably, at baseline, cocaine increasers and decreasers 
showed comparable baseline values in all reported test parameters 
(MET, MASC, SDM, SNQ, SCID-II Cluster B) differing only with 
very small effect sizes (tind(32–35) = 0.05–0.34, p = .99–.74, d = 
0.00–0.11). In the test parameter analysis, frequency data were 
analyzed by the Fisher–Freeman–Halton Exact Test (FET) (45). To 
test for test–retest effects, we applied the Pearson product-moment 
correlation analyses. The confirmatory statistical comparisons 
were carried out on a significance level of p < .05 (two-tailed).
RESULTS
Demographic characteristics and drug use: As shown before (7, 
30), the three experimental groups did not significantly differ 
regarding age, sex distribution, verbal IQ, years of education, 
length of study interval (Table 1), and socioeconomic status 
(Table S1). Still, cocaine-using groups showed significantly 
higher BDI and ADHD-SR sum scores than controls at 
baseline (7, 30). Whereas at baseline both cocaine user groups 
showed comparable cocaine use severity, the cocainetotal hair 
concentrations for increasers (~3-fold increase) and decreasers 
(reduction by the factor 3.5) were significantly different at 
follow-up. Moreover, hair data revealed a clear preference for 
cocaine use compared to other illegal drugs. Finally, in both user 
groups, 8 of 19 participants sought psychiatric or psychological 
treatment during the study interval. The other cocaine users did 
not report any related treatment between baseline and follow-up.
Emotional empathy: The introduced predictors explained a 
significant amount of variance of the EE change scores in the 
multiple regression analysis [F(5,80) = 2.68, p < .05, R2 = .14; 
Table 2]. The strongest predictors were sex (β = −0.25, p < .05) 
and the group contrast cocaine increasers vs. decreasers (β = −0.25, 
p < .05; Figure 1). Post hoc analyses showed that controls and the 
combined cocaine user (CCU) group showed a nonsignificant 
difference in EE with a small to moderate effect size at baseline 
[tind(84) = 1.78, p = .08, d = 0.39]. Whereas in the 1-year interval, 
increasers slightly reduced their already hampered EE [tdep(18) = 
1.19, p = .25 d = 0.27], and cocaine decreasers moderately 
improved their ability to respond empathically [tdep(18) = 1.80, 
p = .09, d = 0.41]. Notably, controls remained largely stable in 
EE [tdep(47) = 0.98, p = .33, d = 0.14]. Accordingly, at follow-up, 
controls differed significantly from the increaser group [tind(25) = 
2.14, p < .05, d = 0.64], whereas the difference between controls 
and decreasers was strongly reduced [tind(65) = 0.40, p = .69, d = 
0.11]. Finally, at follow-up, increasers and decreasers displayed a 
nonsignificant group difference of moderate effect size [tind(36) = 
1.69, p = .10, d = 0.56].
Theory-of-Mind: The applied multiple regression model could 
not predict the MASC total error change scores (Table 2). At 
the phenomenological level, both cocaine user groups displayed 
small test–retest improvements [increasers: tdep(18) = 1.12, p = 
.28, d = 0.26; decreasers: tdep(17) = 0.60, p = .56, d = 0.14], while 
the control group showed pronounced improvements [tdep(47) = 
4.68, p < .001, d = 0.68; Figure 2).
Social interaction: The multiple regression model was also 
not able to predict the SDM composite change score (Table 2). 
From the phenomenological perspective, controls and increasers 
acted less prosocial (giving less money to the opponent), while 
decreasers remained stable but, with that, came closer to the 
controls (Figure 3). Exploratory post hoc analyses confirmed that 
controls and CCU significantly differed at baseline [tind(65)  = 
2.51, p < .05, d = 0.56]. At follow-up, controls and increasers 
still display a moderate group difference [tind(65) = 1.92, p = 
.06, d  = 0.50], whereas the group difference between controls 
and decreasers was reduced to a small effect size [tind(64) = 0.98, 
p = .33, d = 0.26]. In addition, we analyzed behavioral changes 
between baseline and follow-up (more prosocial decisions, more 
self-serving decisions, similar decision) only in cocaine users and 
found that about two-thirds of the increasers (58% = 11/19) but 
only one-third of the decreasers (33% = 6/18) showed more self-
serving decisions at follow-up (p = .40; FET; Figure S1).
Social network size: Regarding the SNQ total network size, the 
multiple regression model could again not substantially predict the 
change scores (Table 2, Figure 4). Interestingly, during the 1-year 
interval, all three groups reported a substantial and moderate 
social network reduction of about 2.5 contacts [controls: tdep(47) = 
3.75, p < .001, d = 0.54; increasers: tdep(17) = 1.94, p = .70, d = 0.46; 
decreasers: tdep(17) = 3.09, p < .01, d = 0.73].
Cluster B PD: The regression model significantly explained the 
variance in cluster B PD symptom change [F(5,77) = 3.25, p < 
.01, R2 = .17; Table 2]. This change score was best predicted by 
the ADHS-SR score (β = −0.32, p < .01) and the group contrasts 
cocaine increasers vs. decreasers (β = 0.34, p < .01) and cocaine 
increasers vs. controls (β = 0.31, p < .01). Importantly, the 
CCU group showed at baseline significantly more cluster B PD 
symptoms than the controls [tind(81) = 4.40, p < .001, d = 0.96; 
Figure 5]. Whereas controls [tdep(47) = 4.91, p < .001, d = 0.71] 
and decreasers [tdep(17) = 3.55, p < .01, d = 0.84] had significantly 
lower symptom scores after the 1-year interval period, the 
amount of symptoms for the increaser group remained largely 
stable [tdep(16) = 0.52, p = .61, d = 0.13]. Accordingly, at follow-up, 
controls differed strongly from the increasers [tind(19) = 4.70, p < 
.001, d = 1.58] and from the decreasers [tind(22) = 3.11, p < .01, d = 
0.96]. Interestingly, already after 1 year of different cocaine use, 
increasers and decreasers displayed a moderate to strong group 
difference in cluster B PD symptoms at follow-up [tind(33) = 1.85, 
p = .07, d = 0.63]. Of note, approximately three quarters of the 
decreasers (13/18) displayed lower cluster B PD scores, while 
more than half of the cocaine increasers (9/17) showed even more 
symptoms at follow-up (p < .05; FET; Figure S2).
Remarkably, the interaction effect on cluster B PD symptoms 
was mainly driven by changes in the narcissistic and borderline 
subscores and less by the histrionic and surprisingly also not by 
the antisocial subscore (see Figure S3a–d). Both the narcissistic 
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and the borderline subscores revealed significant regression 
models (Table S2), but only the borderline subscore was 
significantly predicted by the group contrast cocaine increasers 
vs. decreasers (β = 0.40, p < .01). Compared to baseline, less 
symptoms occurred in controls [tdep(47) = 4.99, p < .001, d = 0.72] 
and decreasers [tdep(17) = 3.16, p < .01, d = 0.75] at follow-up, 
while symptoms remained stable in increasers [tdep(16) = 0.18, p = 
.86, d = 0.04], resulting in a strong group effect between increasers 
and decreasers [tind(33) = 2.57, p < .05, d = 0.87] at follow-up.
Change in alcohol use: As not only cocaine but also alcohol 
intake was increased in increasers (see Table 1), the change in 
alcohol consumption was considered in additional multiple 
regression models. However, alcohol change was not significant 
in any of the main regression models (p-values ranged from .222 
to .659) shown in Table 2, while the interaction effects and also 
the explained variances remained stable, indicating that changes 
in alcohol consumption have not impacted our main results.TA
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FIGURE 1 | Development of emotional empathy in cocaine increasers, 
decreasers, and stimulant-naive controls within 1 year. Mean emotional 
empathy sum scores and standard errors. At baseline, controls vs combined 
cocaine user (CCU) (= Ø of increaser and decreaser). Independent Student’s 
t-tests are shown if p < .10. (*)p < .10; *p < .05.
FIGURE 2 | Development of the Theory-of-Mind in cocaine increasers, 
decreasers, and stimulant-naive controls within 1 year. Mean Movie for the 
Assessment of Social Cognition (MASC) total errors and standard errors. At 
baseline, controls vs CCU (= Ø of increaser and decreaser). Independent 
Student’s t-tests are shown if p < .10. *p < .05.
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Test–retest reliability: In the total sample, all dependent 
variables displayed acceptable to good test–retest reliabilities 
(Table 3). Interestingly, in the SDM paradigm, controls and 
CCU differed significantly in their test–retest reliability (z = 
−3.25; p < .001): While in controls the SDM score showed 
hardly acceptable reliability (r = 0.48; p < .001), it was good in 
the cocaine users (r = 0.85; p < .001).
DISCUSSION
The present longitudinal study investigated the change of social 
cognition, social interaction, and socially relevant cluster B PD 
symptoms in healthy controls and relatively pure and non-help-
seeking chronic cocaine users who clearly increased or decreased 
their cocaine consumption during a 1-year study interval. The 
most striking findings were that i) improved EE correlated with 
decreased cocaine consumption, whereas increased cocaine use 
severity was linked to less EE; and ii) cluster B PD symptom 
burden was lowered in decreasers, whereas increasers showed 
stable severity in these symptoms. Additionally, during the 
study interval, we found an approximation between controls 
and decreasers regarding their prosocial behavior, while the 
large gap between increasers and controls remained. Moreover, 
neither the Theory-of-Mind Task (MASC) nor the social network 
size showed interactions with changing cocaine use, indicating 
that mental perspective-taking (sometimes also interpreted as 
cognitive empathy) and the number of social contacts in the last 
months were not affected by changing drug use during the study 
interval.
Importantly, the present analysis of smaller (longitudinal) 
subgroups from our larger cross-sectional ZuCo2St sample 
published previously (14, 16, 17) still showed significantly 
reduced prosocial behavior, a smaller social network, and 
strongly elevated cluster B personality symptoms in the 
total group of cocaine users at baseline, indicating that these 
indicators of social functioning were robustly altered in this 
population. The EE score of the MET showed only a statistical 
trend between cocaine users and controls at baseline, but the 
present effect size (d = 0.39) was in the range of the previously 
FIGURE 3 | Development of social interaction in cocaine increasers, 
decreasers, and stimulant-naive controls within 1 year. Mean social 
decision-making (SDM) composite z-scores and standard errors. At 
baseline, controls vs CCU (= Ø of increaser and decreaser). Independent 
Student’s t-tests are shown if p < .10. (*)p < .10; *p < .05.
FIGURE 4 | Development of social network size in cocaine increasers, 
decreasers, and stimulant-naive controls within 1 year. Mean total network 
size and standard errors. At baseline, controls vs CCU (= Ø of increaser and 
decreaser). Independent Student’s t-tests are shown if p < .10. **p < .01.
FIGURE 5 | Development of Structured Clinical Interview for DSM-IV Axis 
II Disorders (SCID-II) Cluster B in cocaine increasers, decreasers, and 
stimulant-naive controls within 1 year. Mean SCID-II Cluster B symptoms 
and standard errors. At baseline, controls vs CCU (= Ø of increaser and 
decreaser). Independent Student’s t-tests are shown if p < .10. (*)p < .10; 
**p < .01; ***p < .001.
TABLE 3 | One-year test–retest reliability between baseline and 1-year follow-up 
in controls and cocaine users.
Controls 
(n = 48)
Combined 
cocaine
users (n = 38)
Total sample 
(n = 86)
MET Emotional empathy score 0.66*** 0.79*** 0.74***
MASC total errors 0.67*** 0.60*** 0.63***
SDM composite score 0.48*** 0.85*** 0.70***
SNQ network size 0.75*** 0.81*** 0.80***
SCID-II Cluster B symptoms 0.68*** 0.74*** 0.77***
Pearson’s product-moment correlation. Significance level: ***p < .001.
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reported effect sizes of the larger cross-sectional sample of 
recreational and dependent cocaine users (d = 0.39–0.64), 
suggesting rather a deficiency of power than a lack of reliability. 
This assumption is further supported by the fact that the MET 
EE score showed good test–retest reliability scores. Moreover, 
the MASC did not show any baseline group differences in the 
present subsample of cocaine users underscoring our previous 
conclusion that mainly very severe cocaine users with a 
putative ADHD comorbidity show disturbances in this task 
(16, 44).
While sociocognitive functions represent basic abilities 
in perspective-taking and interaction, more conventional 
psychopathology is aiming at the identification and 
quantification of symptoms in psychiatric disorders (51). 
As such, the research on the relationship between PDs 
and cocaine use is of special interest, as the differentiation 
between predispositions vs. drug-induced effects merges with 
the question if these pathologies are reversible or not. In our 
longitudinal investigation, we found that decreasers of cocaine 
consumption also significantly improved in cluster B PD 
symptoms during 1 year, whereas the increasers showed a stable 
PD symptom burden. This is insofar interesting as in both user 
groups 8 of 19 participants sought psychiatric treatment in the 
interval, but only decreasers improved in some social functions 
and socially relevant PD symptoms.
In general, PDs are defined as typical constellations of 
impaired subjective and behavioral traits that result in suffering 
of the affected individual and/or society (52). These personality 
traits are regarded as relatively stable across time and consistent 
across situations (diagnostically mandatory) (53–56). Moreover, 
cluster B PDs show a higher stability over 12 to 18 years than 
the other clusters (57). However, studies also found considerable 
variability of PD symptoms across individuals over time (58, 
59), questioning the trait-like character of the disorder. An early 
study showed changes in PD symptoms related to treatment in 
substance-dependent patients (60). Interestingly, clusters A and 
C profited most, while cluster B changes were only observed in 
patients with borderline PD. In patients with cocaine addiction, 
cluster B PDs are the most frequent and these patients have 
the most severe courses of illness including worst treatment 
outcomes (24, 26–28, 61, 62). Therefore, cluster B PD symptoms 
are likely personality features that increase the risk for cocaine 
use and the development of an addiction. However, as seen in 
the present study, cluster B PD symptom load is nevertheless 
variable and reduction of consumption leads to a substantial 
improvement in these symptoms. Consequently, a reduction 
of cluster B PD symptom burden again increases likelihood of 
successful treatment, offering the patient an opportunity to leave 
the vicious circle of addiction.
The suggested consumption-dependent variability of social 
behavior as well as cluster B symptoms are well in line with our 
previous analyses from this sample that not only basal cognitive 
functions such as working memory but also self-reported 
impulsivity improve with a strong reduction of cocaine use, while 
they are worsened with increased cocaine consumption (7, 30). 
The present data and the previous analyses from this sample are 
also in accordance with our recent results from an independent 
longitudinal investigation showing that decreased cortical 
thickness (CT) of several regions within the prefrontal cortex 
of cocaine users can improve after a strong reduction of cocaine 
use, while sustained use went along with a further decrease in 
prefrontal CT during the study interval (63). Importantly, the 
cortical changes were correlated with cognitive changes, i.e., 
improved CT as associated with enhanced sustained attention 
(63). Thus, the overall pattern of change shown by longitudinal 
data supports our assumption that sociocognitive impairments 
of cocaine users are at least in part drug-induced and that 
neuroplastic changes in brain regions and neurotransmitter 
systems involved in social cognition, social interaction, and 
social reward processing contribute to a further decrease in 
social contact and social support leading to an increase in social 
isolation, aggression, and depressive symptoms. This ends in 
a further reduction of social reward resources, ongoing social 
withdrawal, and the establishment of cocaine as the main source 
of reward resulting in the maintenance of stimulant use and 
recurrent relapses (15).
While EE is more a perceptive social cognition ability, social 
decision-making (here assessed with a combined Distribution/
Dictator Game) is a form of socially interactive behavior. In 
our previous cross-sectional analysis sample, cocaine users 
cared more about efficiency than about fairness compared to 
healthy controls at baseline (17). This was previously interpreted 
as predisposition of stimulant use (15), as such fairness 
preferences and severity of cocaine use were not correlated (17). 
Intriguingly, utilitarian and opportunistic attitudes assessed with 
the Machiavellianism Questionnaire (MACH-IV) were also 
increased in cocaine users compared to controls and were shown 
to be stable and independent of changing cocaine use (14). 
However, our data indicated a shift toward improved prosocial 
behavior in cocaine decreasers indicating space for enhancement 
potential by treatment. Conclusively, SDM deficits in cocaine 
users likely have both a trait and a state component, and it might 
be worse to specifically target the state component in therapy in 
order to improve the treatment outcome.
Limitations
When interpreting the present results, some limitations of our 
study have to be considered: i) The total sample size is moderate 
for a longitudinal analysis. Moreover, the test–retest reliabilities 
of the applied social cognition tasks and questionnaire have a 
broad range (in controls: r = 0.48–0.75; in cocaine users: r = 
0.60–0.85; in the total sample: r = 0.63–0.80). As a consequence 
of both, the shown interaction effects are not very strong (in 
terms of p-values). However, to our knowledge, these are the 
only existing longitudinal samples of chronic cocaine users 
with objectively verified increasing and decreasing cocaine 
use (by hair testing). Moreover, the included individuals were 
preferably pure cocaine users with little axis-I psychiatric 
comorbidities. We therefore think that the carefully selected and 
homogeneous sample has nonetheless sufficient explanatory 
power. ii) In the context of our hypotheses, we attribute the 
changes in behavior to the changes in cocaine consumption. 
However, we cannot rule out if other changes in the lives of 
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our cocaine users (e.g., positive or negative changes in their 
social environment) not assessed by our test battery may have 
impacted both drug use and social functioning. Future studies 
should therefore assess more information on the social life of 
cocaine users beyond simple parameters such as social network 
size (e.g., social media use).
Conclusions
The aim of this longitudinal study was to investigate whether 
cocaine use is associated with permanent or reversible 
alterations of social cognition and interaction as well as cluster 
B PD symptoms. We found that specific social dysfunctions and 
PD symptoms are variable over time as they seem to depend on 
variations in cocaine use. Thus, strong reduction of cocaine use 
within only 1 year seems to positively affect social dysfunctions 
that are assumed to be crucial factor in the maintenance of 
stimulant addiction (15, 64). From our perspective, the shown 
positive effects of reduced cocaine use clearly favor abstinence-
orientated treatment approaches of cocaine addiction. 
Furthermore, having the strong impact of social cognitive 
abilities as well as prosocial behavior and attitudes on the patient–
therapist relationships in mind (15), future developments in the 
psychotherapy of cocaine addictions should consider trainings 
specifically of social skills and cognitions in order to improve 
treatment outcome.
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Methods S1. Test descriptions. 
 
Multifaceted Empathy Test (MET): The MET is a reliable PC-assisted test comprising 40 
photographs of people in emotionally charged situations (1). The stimuli depict everyday life 
situations conveying information on emotional mental states via facial expression, body language 
and context. To measure CE, subjects are asked to infer the mental state of the person in the 
photograph and choose which of four words provided along with the picture describes best what the 
person in the picture is feeling. Explicit emotional empathy (EEE) is assessed by ratings of 
empathic concern (‘How concerned are you for this person?’) on a visual analog scale within a 
range of 1–9 (1=not concerned to 9=very concerned) while viewing the photograph. Implicit 
emotional empathy (IEE) is measured analogously by arousal ratings (‘How calm/aroused does this 
picture make you feel?’, 1=very calm to 9=very aroused). MET and MASC are implemented in 
Presentation (Version 14.1, Neurobehavioral Systems, Albany, CA, USA). 
 
Movie for the Assessment of Social Cognition (MASC): The MASC was developed as ecologically 
valid and video-based multi-modal (visual and auditory input) test of social cognition (2). 
Participants are asked to watch a 15-minute movie and make inferences about the video characters’ 
mental states requiring the understanding of emotions, thoughts and intentions, and concepts such 
as false belief, faux pas, metaphor and sarcasm in an everyday-life situation (a dinner with friends). 
It is paused at 45 times when questions about the actors’ feelings, thoughts and intentions are asked 
(‘How is Michael feeling?’). These questions are asked in a multiple-choice format with one correct 
answer and three distractors reflecting three different types of mistakes: (1) insufficient mental state 
inferences (undermentalizing: reduced ToM), (2) excessive (overmentalizing) and (3) non-mental 
state inferences (physical causation, no-ToM). Therefore, the MASC provides a sum score for the 
errors and three subscales for different error types. To control for non-social inference, memory and 
general comprehension effects, six control questions referring to physical events instead of a 
character’s mental state are asked during the test. 
 
Distribution/Dictator Game: In the social interaction tasks based on (3, 4), participants were told 
that they would interact with two other study participants in a randomly assigned role of either 
player A or B. In order to warrant anonymity of the drug users, which was necessary for ethical 
reasons and for professional secrecy, a cover story was used where players were told that they 
would interact with the other subjects via Internet connection. For the purpose of this study, we 
were solely interested in the role of player A, wherefore player B was simulated by the computer 
and always responded in the same manner. The instructions specify that both players are informed 
about the other player’s possibilities of action and that the points will be converted into real money 
(Swiss Francs, CHF) at the end of the study. The plausibility of the cover story was controlled by 
the following question at the end of the test battery: “For reasons of anonymity you did not meet 
your interaction partner personally. Did you have any doubts that you interacted with someone?” 
Subjects responded on a five-point scale ranging from 1=not at all to 5=very much. 
 
Social Network Questionnaire (SNQ):  The SNQ is based on the social contact circle interview 
and was designed to evaluate the size of an individual’s social network as well as the experienced 
emotional support and strain by this network (5). Participants are required to write down the names 
of personal contacts in the areas ‘household’, ‘family’, ‘work or apprenticeship’, ‘friends’, 
‘neighbors’ and ‘others’. Only individuals with whom they were in direct contact (via personal 
encounters, phone calls, emails or letters) during the previous 4 weeks should be included. Double 
entries of contacts are not allowed enabling the calcula-tion of the total social network size. 
Furthermore, participants are requested to indicate how strongly they feel emotionally supported 
(e.g. solace and encouragement) by their social contacts on a 5-point scale (1=not at all; 5=very 
much). Analogously, they specify the emotional strain (e.g. feeling of being rejected) they 
experience by their social contacts. 
3 
 
Table S1. Socioeconomic status (number of subjects and percent). 1 
 2 
  Controls (n=48) 
Cocaine  
Increaser 
(n=19) 
Cocaine  
Decreaser 
(n=19) 
0 - 15'000 CHF 20 (41.7%) 7 (36.8%) 5 (26.3%) 
15'000 - 30'000 CHF 11 (22.9%) 3 (15.8%) 3 (15.8%) 
30'000 - 60'000 CHF 6 (12.5%) 5 (26.3%) 5 (26.3%) 
60'000 - 90'000 CHF 5 (10.4%) 2 (10.5%) 6 (31.6%) 
90'000 - 120'000 CHF 3 (6.3%) 2 (10.5%) 0 (0.0%) 
120'000 CHF and more 3 (6.3%) 0 (2.0%) 0 (0.0%) 
  
Fisher-Freeman-Halton Exact Test                F=10.31, p=.36 
Participants were asked how much money they had available over the past year. 3 
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Table S2. Multiple regression analyses of SCID-II Cluster B subscale change values. 1 
 2 
 3 
                                  
 
Histrionic  
personality 
disorder 
Δ Symptoms 
 
Narcisstic  
personality  
disorder 
Δ Symptoms 
 
Borderline  
personality  
disorder 
Δ Symptoms 
 
Antisocial  
personality  
disorder 
Δ Symptoms 
 
  B SE β   B SE β   B SE β   B SE β   
Constant -0.38 0.84 1.88 1.19 -1.98 1.33 -0.52 0.95 
Age -0.01 0.02 -0.05 -0.02 0.03 -0.07 0.01 0.03 0.03 0.04 0.02 0.22*
Sex 0.02 0.37 0.01 -0.91 0.52 -0.18 0.73 0.58 0.13 -0.54 0.42 -0.14
ADHD-SR score  0.00 0.02 -0.02 -0.11 0.04 -0.36** -0.10 0.04 -0.28* -0.02 0.03 -0.07
Controls vs. Cocaine increaser 0.03 0.45 0.01 0.92 0.64 0.16 1.84 0.71 0.29* 1.21 0.50 0.28*
Cocaine decreaser vs.Cocaine  increaser -0.09 0.51 -0.03 1.03 0.72 0.18 2.54 0.81 0.40** 0.95 0.57 0.22 
R2 0.00 0.18 0.20 0.13
F 0.06 3.40** 3.96** 2.20
                                  
Multiple linear regression with the independent variables age, sex, ADHS-SR score, and dummy coded (zero, one) group variables.  4 
To compare the groups, cocaine increaser acted as the reference group.  5 
Dependent variables are change values (Δ = value at t2 - value at t1).  6 
B = Unstandardized regression coefficient; SE = Unstandardized standard error; β = Standardized Beta. *p<.05; **p<.01; ***p<.001. 7 
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 1 
Figure S1 2 
 3 
 4 
 5 
Social behavior as measured by money distribution in cocaine increasers, decreasers and 6 
stimulant-naïve controls at baseline and follow-up.  7 
Distribution Game Payoff  B and  Dictator Game Payoff  B added up. More social behavior: 8 
Participants gave at follow-up more money to the fictional co-player than they did at baseline. More 9 
self-serving behavior: Participants gave at follow-up less money to the fictional co-player B than 10 
they did at baseline. Similar behavior: Participants chose the same money distribution at baseline 11 
and follow-up.  FET, p=.40.    12 
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Figure S2 1 
 2 
 3 
 4 
Changes in SCID-II Cluster B symptoms in cocaine increasers, decreasers and stimulant-naïve 5 
controls within one year.  6 
Amount of Cluster B symptoms according to SCID-II questionnaire. More/ less symptoms refers to 7 
the comparison between follow-up and baseline as stated at follow-up. FET, p<.05.   8 
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Figures S3 1 
 2 
a) 3 
 4 
 5 
b) 6 
  7 
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c) 1 
 2 
 3 
d) 4 
 5 
 6 
Development of SCID-II a) Histrionic, b)Narcisstic, c)Borderline, d) Antisocial personality 7 
disorder in cocaine increasers, decreasers and stimulant-naïve controls within one year.  8 
Mean SCID-II symptoms and SE. At baseline, controls vs CCU (=Ø of increaser and decreaser). 9 
Independent Student’s t-tests are shown if p<.10.  (*)p<.10; *p<.05; **p<.01; ***p<.001. 10 
  11 
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